
Pangenomic unit working on real-world evidence platform
Pangenomic unit working on real-world evidence platform

Pangenomic unit working on real-world evidence platform
Seegnal extends contract with Maccabi for six years
MedX Announces Proposed Extension of Non-Brokered Private Placement
Hydreight signs LOI to acquire Auxano's Dynamic IV
Pharmacorp Rx to acquire Ont. pharmacy for $5.3-million
Cybin completes enrolment in phase 2 study on CYB004
Bausch + Lomb launches Asana lenses in U.S.
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
Revive extends $650,000 private placement
Helix ends review, drops GEM equity facility plan
Bausch's Thermage reaches five million skin treatments
Hemostemix rolls out VesCell.Health in Florida
Hydreight closes $11.5-million debenture offering
Bright Minds work shows BMB-201 outperforms sumatriptan
BRIGHT MINDS BIOSCIENCES ANNOUNCES AT-THE-MARKET OFFERING